COVID antibody drug tested in kids – but study stopped early
NCT ID NCT05092581
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a single dose of casirivimab+imdevimab (REGN-COV2) in children hospitalized with COVID-19. The goal was to see how the drug behaves in the body and whether it is safe. However, the study was terminated early and only enrolled 2 participants, so we have very little information from it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
casirivimab+imdevimab (REGN-COV2, a combination of two monoclonal antibodies)
What this could lead to
If successful, this could provide a treatment option for hospitalized children with COVID-19.
What could go wrong
This was a very early (Phase 1) study that was terminated after enrolling only 2 participants, so results are extremely limited and may not be reliable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Le Bonheur Children's Hospital
Memphis, Tennessee, 38103, United States
-
State University of New York at Stony Brook
Stony Brook, New York, 11794, United States